Quadrant's gyms bulk up in Asia ahead of sale
Australia's biggest gyms business, Quadrant Private Equity's Fitness and Lifestyle Group, has spent more than $200 million on an acquisition in Asia, Street Talk can reveal.
ResMed shares drop on disappointment
ResMed shares dropped 8 per cent in early trading after its second-quarter revenue, which was up by 8 per cent, came in below expectations.
Lessons from Atlassian's unconventional tycoon
Mike Cannon-Brookes has made a career – and a fat fortune – with a 'no bullshit' approach that he's bringing to two election campaigns, he tells Lunch with the AFR.
The race to stop genetically-engineered humans
Researchers are asking themselves how they can stop a repeat of a rogue Chinese scientist who created the first genetically edited babies - twins, born in November.
API expects Sigma due diligence 'soon'
API chairman Mark Smith has defended the company's proposed $730 million cash and scrip offer for rival Sigma.
Scientists are teaching the body to accept new organs
Researchers are trying new procedures to achieve something that transplant surgeons have dreamed of for more than 65 years – cut down on th...
API investor wary of Sigma merger
API investor Andy Gracey says a proposal from the drug wholesaler to merge with Sigma Healthcare throws a lifeline to an under-pressure riva...
GSK chairman to step down ahead of break-up
Philip Hampton has announced he will step down as chairman of GlaxoSmithKline just a month after the UK drug-maker announced a break-up that...
I tried to develop a new drug for a deadly cancer
When two young scientists set out to create a new drug, the science turned out to be the easy part.
Pot stock Creso Pharma seeks fresh funds
Stockbroker EverBlu Capital is in the market seeking to raise equity for ASX-listed medical cannabis hopeful Creso Pharma.
